Page 825 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 34 Miscellaneous Tumors 803

215. Kegler K, Habierski A, Hahn K, et al.: Vaginal canine transmis- 234. Liu CC, Wang YS, Lin CY, et al.: Transient downregulation of
sible venereal tumour associated with intra-tumoural Leishmania monocyte-derived dendritic-cell differentiation, function, and sur-
spp. Amastigotes in an asymptomatic female dog, J Comp Path vival during tumoral progression and regression in an in vivo canine
VetBooks.ir 216. Decker B, Dais BW, Rimbault M, et al.: Comparison against 186 model of transmissible venereal tumor, Cancer Immunol Immuno-
149:156–161, 2013.
ther 57:479–491, 2008.
canid whole-genome sequences reveals survival strategies of an
in cancers that break the rules of transplantation, Cancer Immunol
ancient clonally transmissible canine tumor, Genome Res 25:1646– 235. Fassati A, Mitchison NA: Testing the theory of immune selection
1655, 2015. Immunother 59:643–651, 2010.
217. Strakova A, Leathlobhair MN, Wang G-D: Mitochondrial genetic 236. Hsiao YW, Liao KW, Chung TF, et al.: Interactions of host IL-6
diversity, selection and recombination in a canine transmissible and IFN-γ and cancer-derived TGF-ß1 on MHC molecule expres-
cancer, eLife 5:e14552, 2016. sion during tumor spontaneous regression, Cancer Immunol Immu-
218. Katzir N, Rechavi G, Cohen JB, et al.: “Retroposon” insertion into nother 57:1091–1104, 2008.
the cellular oncogene c-myc in canine transmissible venereal tumor, 237. Ballestero Fêo H, Montoya Flórez L, Yamatogi RS, et al.: Does
Proc Natl Acad Sci USA 82:1054–1058, 1985. the tumour microenvironment alter tumorigenesis and clinical
219. Choi YK, Kim CJ: Sequence analysis of canine LINE-l elements response in transmissible venereal tumour in dogs? Vet Comp Oncol
and p53 gene in canine transmissible venereal tumor, J Vet Sci 16:370–378, 2018.
3:285–292, 2002. 238. Chiang HC, Liao AT, Jan TR, et al.: Gene-expression profiling to
220. Fonseca LS, Mota LSLS, Colodel MM, et al.: Spontaneous canine identify genes related to spontaneous tumor regression in a canine
transmissible venereal tumor: association between different phe- cancer model, Vet Immunol Immunopathol 151:207–216, 2013.
notypes and the insertion LINE‐1/c‐myc, Rev Colomb Cienc Pec 239. Frampton D, Schwenzer H, Marino G, et al.: Molecular signatures
25:402–408, 2012. of regression of the canine transmissible venereal tumor, Cancer
221. Strakova A, Murchison EP: The cancer which survived: insights Cell 33:620–633, 2018.
from the genome of an 11 000 year‐old cancer, Curr Opin Genet 240. Cohen D: Detection of humoral antibody to the transmissible
Dev 30:49–55, 2015. venereal tumour of the dog, Int J Cancer 10:207–212, 1972.
222. Liao KW, Lin ZY, Pao HN, et al.: Identification of canine transmis- 241. Calvert CA, Leifer CE, MacEwen EG: Vincristine for treatment
sible venereal tumor cells using in situ polymerase chain reaction of transmissible venereal tumor in the dog, J Am Vet Med Assoc
and the stable sequence of the long interspersed nuclear element, 181:163–164, 1982.
J Vet Diagn Invest 15:399–406, 2003. 242. Yang TJ, Palker TJ, Harding MW: Tumor size, leukocyte adher-
223. Castro KF, Strakova A, Tinucci-Costa M, et al.: Evaluation of a ence inhibition and serum level of tumor antigen in dogs with the
genetic assay for canine transmissible venereal tumour diagnosis in canine transmissible venereal sarcoma, Cancer Immunol Immuno-
Brazil, Vet Comp Oncol 15(2):615–618, 2017. ther 33:255–262, 1991.
224. Sánchez-Servín A, Martínez S, Cárdova-Alarcon E, et al.: TP53 243. Batamuzi EK, Kristensen F: Urinary tract infection: the role of
polymorphisms allow for genetic sub-grouping of the canine trans- canine transmissible venereal tumour, J Small Anim Pract 37:276–
missible venereal tumor, J Vet Sci 10(4):353–355, 2009. 279, 1996.
225. Stockman D, Ferrari HF, Andrade AL, et al.: Detection of the 244. Amber EI, Henderson RA, Adeyanju JB, et al.: Single-drug che-
tumour suppressor gene TP53 and expression of p53, Bcl-2 and motherapy of canine transmissible venereal tumor with cyclophos-
p63 proteins in canine transmissible venereal tumour, Vet Comp phamide, methotrexate, or vincristine, J Vet Intern Med 4:144–147,
Oncol 9(4):251–259, 2011. 1990.
226. Fenton MA, Yang TJ: Role of humoral immunity in progressive 245. Singh J, Rana JS, Sood N, et al.: Clinico-pathological studies on
and regressive and metastatic growth of the canine transmissible the effect of different anti-neoplastic chemotherapy regimens on
venereal sarcoma, Oncology 45:210–213, 1988. transmissible venereal tumours in dogs, Vet Res Comm 20:71–81,
227. Perez J, Day MJ, Mozos E: Immunohistochemical study of the 1996.
local inflammatory infiltrate in spontaneous canine transmissible 246. Nak D, Nak Y, Cangul IT, et al.: A clinico-pathological study on
venereal tumour at different stages of growth, Vet Immunol Immu- the effect of vincristine on transmissible venereal tumour in dogs,
nopathol 64:133–147, 1998. J Vet Med A 52:366–370, 2005.
228. Hsiao YW, Liao KW, Hung SW, et al.: Effect of tumor infiltrat- 247. Scarpelli KC, Valladão ML, Metze K: Predictive factors for the
ing lymphocytes on the expression of MHC molecules in canine regression of canine transmissible venereal tumor during vincristine
transmissible venereal tumor cells, Vet Immunol Immunopathol therapy, Vet J 183:362–363, 2010.
87:19–27, 2002. 248. Fathi M, Ashry M, Ali KM, et al.: Clinico-pathological evalu-
229. Liao KW, Hung SW, Hsiao YW, et al.: Canine transmissible vene- ation and treatment outcomes of canine transmissible venereal
real tumor cell depletion of B lymphocytes: molecule(s) specifically tumor using three different protocols, Pak Vet J 38(2):204–208,
toxic for B cells, Vet Immunol Immunopathol 92:149–162, 2003. 2018.
230. Hsiao YW, Liao KW, Hung SW, et al.: Tumor-infiltrating lym- 249. Thrall DE: Orthovoltage radiotherapy of canine transmissible vene-
phocyte secretion of IL-6 antagonizes tumor-derived TGF-βl real tumors, Vet Radiol 23:217–219, 1982.
and restores the lymphokine-activated killing activity, J Immunol 250. Idowu AL: A retrospective evaluation of four surgical methods of
172:1508–1514, 2004. treating canine transmissible venereal tumour, J Small Anim Pract
231. Siddle HV, Kaufman J: Immunology of naturally transmissible 25:193–198, 1984.
tumours, Immunology 144(1):11–20, 2015. 251. Amber EI, Henderson RA: Canine transmissible venereal tumor
232. Gonzalez CM, Griffey SM, Naydan DK, et al.: Canine transmis- evaluation of surgical excision of primary and metastatic lesions in
sible venereal tumour: a morphological and immunohistochemical Zaria-Nigeria, J Am Anim Hosp Assoc 18:350–352, 1982.
study of 11 tumours in growth phase and during regression after 252. Knapp DW, Richardson RC, Bottoms GD, et al.: Phase I trial of
chemotherapy, J Comp Path 122:241–248, 2000. piroxicam in 62 dogs bearing naturally occurring tumors, Che-
233. Mukaratirwa S, Chimonyo M, Obwolo M, et al.: Stromal cells and mother Pharmacol 29:214–218, 1992.
extracellular matrix components in spontaneous canine transmissi- 253. Ahmed M, Liu Z, Afzal KS, et al.: Radiofrequency ablation: effect
ble venereal tumour at different stages of growth, Histol Histopathol of surrounding tissue composition on coagulation necrosis in a
9:1117–1123, 2004. canine tumor model, Radiology 230:761–767, 2004.